INFORMATIVE: No Discretionary Denial Where Prior IPR Suggests Material Error By Office

The Acting Director ssued a decision declining to exercise discretionary denial in three related inter partes reviews (“IPRs”) filed by Padagis US LLC (“Padagis”): IPR2025-00464, IPR2025-00465, and IPR2025-00466 (collectively, “the Padagis IPRs”). These IPRs challenge U.S. Patent Nos. 8,895,546; 11,241,414; and 11,793,786, respectively, each of which is assigned to Neurelis, Inc. (“Neurelis”). On January 9, 2026, current USPTO Director John Squires designated the decision as informative.

Neurelis filed a request for discretionary denial, arguing that the proceedings should be denied institution in light of an upcoming district court trial scheduled for February 9, 2026—a date well before the projected final written decision due date of September 17, 2026. The Acting Director acknowledged that this timing factor ordinarily weighs in favor of discretionary denial.